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Introduction
Differentiation of hematopoietic progenitors in the lymphoid
lineage, and the choice of effector function at later stages of
this pathway depend on the tightly controlled activation and
repression of a number of genes (Fisher, 2002). The precise
coordination of these pathways is essential for the proper
development of the immune system, and their deregulation
plays an important role in the pathogenesis of hematopoietic
malignancies.
A number of transcriptional regulators play a critical role at
specific stages of T- and B-cell differentiation, presumably by
regulating the expression of genes whose products affect the
fate and function of lymphoid cells. The Ikaros family of
proteins is a prime example of such factors (Georgopoulos et
al., 1992). Early studies demonstrated that the proteins encoded
by the Ikaros gene are essential for the proper development of
the lymphoid arm of the hematopoietic system (Cortes et al.,
1999). Subsequent studies with null and dominant-negative
Ikaros mutants led to the identification of Aiolos (also known
as IKZF3), Helios (IKZF2), Eos (IKZF4) and Pegasus (IKZF5)
(Wang et al., 1998; Morgan et al., 1997; Honma et al., 1999;
Perdomo et al., 2000).
Aiolos, the second Ikaros family member to be identified
(Morgan et al., 1997), is particularly interesting for several
reasons. Firstly, disruption of Aiolos leads to an increase in
pre-B and immature B cells and to a severe reduction in
circulating B cells (Wang et al., 1998). Moreover, Aiolos is also
specifically required for the generation of long-lived, high-
affinity plasma cells in the bone marrow, which are responsible
for long-term immunity in humans (Cortes and Georgopoulos,
2004). In addition, Aiolos null mice display B-cell
hyperproliferation and develop lymphomas, suggesting that
this gene may have a role in tumor suppression (Wang et al.,
1998). Furthermore, the elevated serum antibody levels and
autoantibody formation in Aiolos null mice suggest its
involvement in autoimmune disease (Wang et al., 1998; Sun et
al., 2003). Finally, Aiolos is also involved in regulation of
apoptosis via interactions with Ras and Bcl-xL in the cytoplasm
and also by exercise of transcriptional control over Bcl-2 gene
expression (Romero et al., 1999; Rebollo et al., 2001).
Each of the Ikaros family members is characterized by the
presence of up to four N-terminal DNA-binding zinc fingers
and two C-terminal zinc fingers required for homo- and
heterodimerization with other family members. Extensive
alternative mRNA splicing of exons of Ikaros, Helios and
Aiolos results in the expression of multiple isoforms of each
protein that are differentially expressed in unique subsets of
hematopoietic cells. The isoforms thus far described can be
divided in two groups: those that possess at least three zinc
fingers at the N-terminus and that bind DNA, and those with
fewer than three N-terminal zinc fingers that are unable to bind
DNA. Isoforms that cannot bind DNA but retain the capacity
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to dimerize are considered to act in a dominant-negative
fashion (Molnar and Georgopoulos, 1994; Kelley et al., 1998;
Klug et al., 1998; Payne et al., 2001).
Several reports provide clues about how Ikaros family
proteins regulate gene transcription. Aiolos and Ikaros proteins
both recruit the Mi-2/NuRD and SIN3 histone deacetylase
(HDAC)-containing repressor complexes (Koipally et al.,
1999; Kim et al., 1999), and also the nucleosome-remodeling
complex SWI/SNF to transcriptionally silenced regions of the
genome (Kim et al., 1999; Koipally and Georgopoulos, 2002a;
Georgopoulos, 2002). Additionally, Aiolos and Ikaros
associate with CtBP-interacting protein (CtIP), which has been
linked with HDAC-independent mechanisms of repression
(Koipally and Georgopoulos, 2002b). To date, there have been
no reports exploring the differential ability of isoforms to
recruit these chromatin-modifying complexes.
Given the important role played in lymphoid development
and apoptosis by the Aiolos gene in humans and mice, we need
a better understanding of the various Aiolos isoforms present
in the cell, and to address the physiological effects of the
presence of functional domains.
In this article, we report our investigation into the type and
functional significance of Aiolos isoforms. We have identified
novel Aiolos transcripts in the peripheral blood of normal
human subjects and in various cell lines derived from
hematological malignancies. In order to study the functional
differences between isoforms, we have cloned and expressed
in mammalian cells five Aiolos isoforms with potentially
different properties arising from their distinctive structures. We
report the first direct comparison of the distribution, the
association with components of the Mi-2/NuRD and SIN3
histone deacetylase complexes, the effects on the global levels
of histone acetylation and direct binding to putative targets.
Our results shed light on the relevance of the generation of
complex patterns by multiple distinct functional Aiolos
isoforms, some of which feature a partial loss of function. This
implies the existence of combinatorial mechanisms that allow
fine regulation by Aiolos.
Results
Identification of novel Aiolos isoforms
We first investigated the pattern of expression of different
Aiolos isoforms in cell lines derived from B and T cell
lymphoid malignancies. RT-PCR analysis of the Aiolos gene
expression revealed nine novel Aiolos splicing variants (Fig.
1A) in addition to the seven isoforms previously reported
(Liippo et al., 2001; Nakase et al., 2002) (Fig. 1B), although
no characteristic isoform expression patterns were associated
with any particular cell or sample type. Direct sequencing of
the RT-PCR products enabled the characterization of these
Aiolos variants, which we have systematically annotated after
the exon that is missing. The isoforms are referred to here as
Aio-2 (lacking exon 2), Aio-3 (lacking exon 3), Aio-2,5
(lacking exons 2 and 5), Aio-3,4 (lacking exons 3 and 4), Aio-
3,4,5 (lacking exons 3, 4 and 5), Aio-3,4,5,6 (lacking exons
3, 4, 5 and 6), Aio-4,5,6 (lacking exons 4, 5 and 6). The
mRNA splice variants Aio-2, Aio-3 and Aio-2,5 encode
proteins with at least three N-terminal zinc-finger motifs within
the DNA binding domain and, based on the properties of the
highly homologous region of Ikaros, should retain the ability
to bind DNA. The mRNAs Aio-3,4, Aio-3,4,5, Aio-4,5,6
and Aio-3,4,5,6 encode proteins lacking several zinc fingers
within the DNA binding domain, which suggests they are
unable to bind DNA and may act as dominant-negative
isoforms (Molnar and Georgopoulos, 1994; Sun et al., 1996;
Kelley et al., 1998; Klug et al., 1998; Payne et al., 2001; Sun
et al., 1999).
Interestingly, the RT-PCR analysis also revealed two novel
mRNAs derived from Aio-1 and Aio-4 that contained a 126
bp insertion between exons 5 and 6. Direct sequencing of both
variants showed that the insertion is derived from the Aiolos
intron sequence between exons 5 and 6, and that it is flanked
by splice donor and acceptor consensus sequences. We
therefore consider this to be a novel exon, which we have called
exon 5a. Accordingly, the two new variants containing exon 5a
were named Aio-1-5a and Aio-4-5a (lacking exon 4),
respectively (Fig. 1B). The insertion of exon 5a introduces a
stop codon into the Aiolos open reading frame and the encoded
proteins have a distinct C-terminal region (Fig. 1B) that lacks
the dimerization domain. All Aiolos isoforms previously
described by other groups harbor the two C-terminal zinc
finger motifs and may therefore form homo- and heterodimers
(Liippo et al., 2001; Nakase et al., 2002). In addition, we used
B cells from healthy subjects (15 samples) and from
individuals diagnosed with systemic lupus erythematosus (10
samples) and rheumatoid arthritis (15 samples), two common
autoimmune diseases (Fig. 1D). Aio-1 was in all cases the most
abundant mRNA species in all the samples analyzed, although
variable amounts of the different isoforms were observed. No
obvious patterns in the expressed specific splice variant were
found to be associated with any particular group of samples.
We also performed RT-PCR analysis of Aiolos gene
expression in non-hematopoietic human cells such as the breast
cancer cell line MCF 7, the hepatic cancer cell line HEPG2,
the renal cancer cell line HEK, and a neuroblastoma-derived
cell line SHSY-5Y. PCR products were transferred onto a nylon
membrane and hybridized with a specific probe corresponding
to a common region of all Aiolos isoforms in order to confirm
the identity of the PCR bands (Fig. 1C). This analysis revealed
that these cell lines express Aiolos isoforms in different
proportions (Fig. 1C). COS-7 cells, by contrast, were found to
be negative for Aiolos expression. No striking differences in
the expressed specific splice variant were found to be
associated with any particular cell type, tumorigenic potential
or autoimmune disease.
Analysis of selected Aiolos isoforms
The presence of distinct recognized functional domains in the
various Aiolos isoforms suggests that cells make use of
combinations of different functional domains of the protein to
modulate their function. In order to investigate the possible
existence of distinct roles, we selected and cloned five Aiolos
isoforms and generated their corresponding constructs for
transfection in mammalian cells. The criteria for selection were
based on choosing isoforms containing or lacking different
well-defined functional domains. Aio-1, which can be
considered the full-length isoform, contains all the exons and
is the most abundant variant among the entire panel of cell
types analyzed. Aio-1-5a, maintains an intact DNA binding
domain but possesses a C-terminus that is different from all the
other isoforms and, therefore, lacks the two C-terminal zinc
fingers involved in homo- and heterodimerization. In Aio-5,
Journal of Cell Science 120 (15)
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one of the zinc fingers at the N-terminus is missing, but the
protein retains the ability to associate with DNA. The isoforms
Aio-3,4,5 and Aio-3,4,5,6 have lost the DNA binding
domain but retain the dimerization domain (Fig. 2A).
The cDNAs of Aiolos isoforms Aio-1, Aio-1-5a, Aio-5,
Aio-3,4,5 and Aio-3,4,5,6 were subcloned into an
expression vector containing a sequence encoding the FLAG
epitope. For transient transfection experiments, we selected
COS-7 cells, which do not express either the Aiolos or the
Ikaros genes (see Fig. 1C) (Cobb et al., 2000; Koipally and
Georgopoulos, 2002a), providing a system in which the
individual effects of Aiolos isoforms can be investigated
without interference with endogenous Aiolos or Ikaros (for
instance, through dimerization). In addition, COS-7 cells
constitute an excellent system for this type of study where
transfection is achieved at a very high efficiency and cells are
convenient for immunocytochemistry experiments. After
transfection, the presence of stable recombinant Aiolos
proteins in COS-7 cell extracts was verified by western blot
with both a mouse monoclonal anti-FLAG antibody and a
polyclonal anti-Aiolos antiserum of transfected COS-7 cell
extracts. As shown in Fig. 2B, all the constructs were properly
transcribed and produced stable proteins in COS-7 cells.
Isoform-specific cell distribution of the Aiolos variants
Before doing a functional study, we investigated the individual
localization of the five Aiolos isoforms. The distribution of the
different Aiolos isoforms, transiently transfected in COS-7
cells, was determined by immunofluorescence and confocal
microscopy using a mouse monoclonal anti-FLAG antibody.
These immunocytochemistry experiments revealed an
isoform-specific cell distribution in the Aiolos isoforms. Aio-
Fig. 1. The Aiolos gene codes multiple isoforms. (A) A representative RT-PCR with primers corresponding to exon 1 and 7 in hematopoietic
cell lines derived from human B leukemic (697, RAMOS, RS11;846, REH) and T leukemic (JURKAT, SUPT11) cells and the NKL cell line,
derived from natural killer (NK) cells. (B) Schematic representation of Aiolos isoforms. Green boxes in exons 3-5 indicate the four N-terminal
zinc finger motifs involved in DNA binding and the two violet boxes in exon 7 indicate the C-terminal motifs required for dimer formation. The
two Aiolos isoforms (at the bottom) contain an alternative exon, which we have named exon 5a (see Results). Aiolos isoforms have been named
according to the exons missing from the full-length isoform. Ikaros full-length isoform Ik-1 is also shown at the bottom. Nine novel Aiolos
isoforms are indicated on the right by asterisks. (C) RT-PCR analysis of non-hematopoietic human cell lines (monkey SV40-transformed
fibroblast cell line COS-7, breast cell line MCF 7, liver cell line HEPG2, a neuroblastoma-derived cell line SHSY-5Y and kidney cell line HEK)
also show the presence of multiple Aiolos isoforms. Molecular weight (MW) markers are included. PCR products were transferred onto a nylon
membrane and hybridized with a specific C-terminal Aiolos probe in order to confirm the identity of the PCR bands (bottom panel).
(D) Representative RT-PCR analysis of B cells including B-cell-derived lymphoblastoid cells (B-PBL), and samples from healthy subjects
(N1-N4) and individuals with systemic lupus erythematosus (SLE1-SLE4) and rheumatoid arthritis (RA1-RA4).
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1, the full-length isoform of Aiolos, and Aio-5, the isoform
lacking just one zinc finger, are both present in nuclei, but are
excluded from the nucleoli. These two isoforms exhibit a
similar pattern of distribution in COS-7 cells and two
populations can be distinguished. 70-80% of the cells have a
diffuse nuclear distribution, tending to concentrate in the
perinuclear heterochromatin. The remaining 20-30% of the
cells have a more restricted distribution with speckles of
variable diameter (1-6 m) (Fig. 2C). These data are consistent
with previous reports of a cell-cycle-dependent distribution of
Ikaros (e.g. Brown et al., 1997). Brown and coworkers also
observed a striking coincidence between Ikaros and DAPI
staining. S-phase cells appeared to express similar levels of
Ikaros to G1-phase cells but distributed as a fine haze, whereas
cells in G1 and G2 phases exhibited a pattern of intense foci
(Brown et al., 1997; Dovat et al., 2002).
By contrast, the Aio-3,4,5,6 isoform, which lacks the
DNA-binding domain, was predominantly localized in the
cytoplasm (Fig. 2C) and cytoplasmic membrane, similar to the
distribution described for the Ikaros dominant-negative
isoforms (Morgan et al., 1997; Romero et al., 1999). The fact
that the Aio-3,4,5,6 variant maintains the dimerization
domain and may be able to bind other nuclear proteins could
account for why a small fraction localizes to the nucleus. Aio-
3,4,5, which also lacks the ability to bind DNA and differs
from the previous isoform only in the presence of exon 6, was
found throughout the nucleus, except in the nucleolus (Fig.
2C). This suggests that, besides the contribution of the DNA-
binding domain to target Aiolos to the DNA within the nucleus,
exon 6 may account for the import of this protein into the
nucleus. This notion is supported by the findings of studies of
isoform Aio-1-5a (see Fig. 2C), which possesses an intact DNA
binding domain but a distinct C-terminal region that contains
exon 5a, but not exons 6 and 7, and shows both a nuclear and
cytoplasmic punctuate distribution.
Ikaros and Aiolos distribution are modulated through
heterodimerization in an isoform-dependent fashion
All the transfected Aiolos isoforms except isoform Aio-1-5a
have a dimerization domain at their C-terminus. Previous
studies of Ikaros and Aiolos have shown that this domain
enables these proteins to form both homo- and heterodimers
with other proteins of the family (Morgan et al., 1997;
Georgopoulos et al., 1997). It has also been shown that Helios
forms multimeric complexes with Ikaros in hematopoietic cells
(Hahm et al., 1998). In order to investigate how the formation
of heterodimers influences subcellular localization, we
cotransfected COS-7 cells with Ikaros-1 (Ik-1) and the Aiolos
isoforms. We then performed immunocytochemistry and
confocal microscopy with the anti-FLAG and anti-Ikaros
antibodies.
We observed that Ikaros-1 has an identical pattern of
localization to that of Aio-1 isoform. In these experiments, we
found a 90-98% colocalization between Ik-1 and all Aiolos
isoforms, except Aio-1-5a. As shown in Fig. 3, isoforms Aio-
1 and Aio-5 colocalize with Ik-1 isoform in the cell nucleus
and their distribution is identical to that of Aiolos in single
transfection experiments, where 80% of the cells exhibit a
diffuse nuclear pattern and 20% have a speckled pattern that is
restricted to heterochromatic regions. Aio-3,4,5 also
Journal of Cell Science 120 (15)
Fig. 2. Transfection of Aiolos isoforms in mammalian cells. (A) Schematic representation of the five selected isoforms. (B) Western blot of
COS-7 cells extracts transfected with the five Aiolos isoforms and developed with the mouse monoclonal anti-FLAG antibody (left) and a
polyclonal anti-Aiolos antiserum (right). (C) Subcellular localization of Aiolos isoforms. Confocal images of COS-7 cells transfected with
different Aiolos isoforms and labeled with antibody to Aiolos (green). Nuclear DNA was counterstained with DAPI (blue). Images of different
subpopulations are included (indicated in Results).
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colocalizes with the Ik-1 isoform. However, although the same
type of distribution as that of the single transfection of Aio-
3,4,5 was seen in the majority of the cells, in approximately
10% of the cells it had a more localized distribution pattern.
Interestingly, cotransfection of Aio-3,4,5,6 with Ik-1 result in
mutual influence in the localization patterns. Ik-1, which in the
absence of Aiolos is located exclusively in the nucleus, when
expressed in the presence of Aio-3,4,5,6, is also found in the
cytosol, where these two proteins colocalize to an extent of
more than 90% (Fig. 3). Conversely, the presence of Ik-1, and
subsequent heterodimerization with Aio-3,4,5,6, moves this
isoform into the nucleus (Fig. 3). We can hypothesize that
isoforms lacking DNA-binding domains play a role in
sequestering or quenching other isoforms through
heterodimerization. This ability would confer a dominant-
negative character on this type of Aiolos isoform, as already
suggested in early work by Molnar and Georgopoulos (Molnar
and Georgopoulos, 1994).
Finally, although both Ik-1 and Aio-1-5a localize in the
nucleus, the slight overlap between them can be easily
explained by the absence of the dimerization domain in the
Aio-1-5a isoform.
Differential isoform-specific association with histone
deacetylase-containing complexes
Previous data indicate that Aiolos interacts with Mi-2/NuRD
and SIN3 histone deacetylase complexes (Koipally et al.,
1999). There is also an association between Aiolos and
SWI/SNF complexes (Kim et al., 1999). However, all these
studies were carried out using the Aio-1 isoform. Here we have
examined the possibility that Aiolos isoforms vary in their
degree of association with histone deacetylase-containing
complexes. We performed immunoprecipitation of total
extracts from transfected COS-7 cells with anti-FLAG
antibodies, followed by western blot with several antibodies
against HDAC1, a histone deacetylase common to the SIN3
and Mi-2/NuRD complexes. In addition, to determine the
specific association with the Mi-2/NuRD and SIN3 complexes,
we used antibodies against SIN3A, and MTA1, MTA2 and
MTA3, which have been shown to define three different
subfractions of the Mi-2/NuRD complex (Bowen et al., 2004;
Fujita et al., 2003; Fujita et al., 2004).
Analysis of immunoprecipitated fractions showed
that comparable amounts of Aiolos isoforms
coimmunoprecipitated significantly different amounts of the
above factors (Fig. 4A). We observed that Aio-1 has the
strongest affinity for both HDAC1 and Mi-2/NuRD subunit
MTA2 relative to the other isoforms (Fig. 4A). No interactions
with MTA1 and MTA3 were observed. Therefore, our data
indicate that Aiolos specifically recruits the MTA2 subfraction
of the Mi-2/NuRD complex. Only Aio-1 also appeared to
interact with SIN3A.
We then studied the colocalization of Aiolos isoforms
with HDAC1, SIN3 and MTA2 in COS-7 cells by
immunocytochemistry and confocal microscopy. We observed
that in control untransfected COS-7 cells these three factors
have a homogeneous localization, similar to the pattern
described by others (Yang et al., 2002; Humphrey et al., 2001)
(Fig. 4B).
We found that that is more than 90% colocalization of the
Aio-1 isoform with HDAC1 and MTA2 (Fig. 4C). By contrast,
transfection with Aio-1 did not change the diffuse pattern of
SIN3A. This is in agreement with the results obtained from the
immunoprecipitation study (Fig. 4A).
In Aio-5- and Aio-3,4,5-transfected cells, similar
patterns of distribution of Aiolos and HDAC1 and MTA2 were
observed, although the levels of colocalization were
significantly lower than those in Aio-1. Colocalization between
Aio-3,4,5,6 and Aio-1-5a with HDAC1 and MTA2 is very
slight (Fig. 4C), as expected from their structures.
Functional effects of Aiolos isoforms on histone
modifications
Once we had confirmed the association of Aiolos isoforms
with histone deacetylase complexes, and the varying degrees
of colocalization, we investigated the direct effects of Aiolos
isoforms on the acetylation patterns of histones. To this end,
we used two methods to analyze the acetylation levels of
histones H3 and H4 in COS-7 cells transfected with the Aiolos
isoforms: western blot with specific antibodies against
different histone acetylation sites, and capillary electrophoresis
of HPLC-fractionated histone fractions (see Materials and
Methods). Interestingly, we found that transfection with Aio-
1, Aio-5 and Aio-1-5a significantly affected the global
acetylation levels of histones H3 and H4 (Fig. 5A), whereas no
differences were observed for Aio-3,4,5 and Aio-3,4,5,6
when compared with mock-transfected cells. Changes were
observed not only with antibodies against hyperacetylated
Fig. 3. Subcellular localization in COS-7 cells of Aiolos isoforms
cotransfected with Ikaros-1. Aiolos isoforms were labeled with Cy2
(green) and Ikaros-1 was labeled with Cy3 (red). Nuclei were
counterstained with DAPI (blue).
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histones H3 and H4, but also with antibodies specific for
certain lysine amino acid residues, such as K8 and K16 of
histone H4 and K9 of histone H3.
We also used high-performance capillary electrophoresis
(HPCE) to quantify global acetylation levels of histone H4 in
the COS-7 cells before and after transfection with the five
Aiolos isoforms. Around 40% of total histone H4 was found
to be constitutively acetylated in COS-7 cells (35.9±1.3) or
mock-tranfected COS-7 cells (36.2±1.0), which is similar to
the basal acetylation levels previously found in immortalized
human cell lines (Fraga et al., 2005). Transfection with the
construct encoding Aio-1 resulted in a decrease in the levels of
histone H4 acetylation (percentage relative acetyl H4 of
29.4±0.9) which was found to be statistically significant (t-test
with respect to mock-transfected control, P=0.0009; Fig. 5C),
primarily as a result of the loss of monoacetylated histone H4.
Expression of the isoforms Aio-1-5a and Aio-5, which
maintain the ability to bind DNA, also caused a decrease in
global H4 acetylation (percentage relative global acetyl H4 of
30.5±1.1 and 32.7±0.8, respectively) statistically significant
(P=0.0027 and P=0.0091 as calculated by t-test comparison of
means) although overexpression of isoforms not expected to
bind DNA (Aio-3,4,5 and Aio-3,4,5,6) did not result in any
change in the global histone H4 acetylation status (36.8±1.2
and 37.2±1.4; Fig. 5C) as confirmed by t-tests (P=0.543 and
0.371, respectively).
Aiolos isoforms differentially associate with the promoter
of target genes
As a member of a family of transcriptional regulators, we
would expect transfection with Aiolos to lead to a change in
the expression pattern of a number of genes. We have used
microarrays to analyze gene expression of COS-7 cells
transfected with Aiolos isoform Aio-1 (data not shown).
Introduction of Aiolos resulted in both overexpression and
downregulation of a number of genes (R.C., M.A., M.E.,
R.G.-S. and E.B., unpublished). Among the genes that were
validated by quantitative real-time RT-PCR, several key genes
are of note. It is remarkable that transfection of COS-7 cells
with Aio-1 resulted in a consistent 20% downregulation of
SIRT1 (silent mating type information regulation 2, SIR2,
homolog), a class III NAD-dependent histone deacetylase that
is thought to participate in the formation of facultative
heterochromatin (Vaquero et al., 2004).
Changes in the expression levels of a gene may have two
possible causes: direct association of Aiolos with the
regulatory region of the target gene, or indirect regulation
through changes in the expression of another transcriptional
factor, targeted by Aiolos, and consequent deregulation of a
number of downstream targets. Thus, we decided to investigate
the association of Aiolos Aio-1 with the promoter of a number
of dysregulated genes, including the SIRT1 promoter, and to
compare the association of the remaining Aiolos isoforms, by
Journal of Cell Science 120 (15)
Fig. 4. Association of Aiolos isoforms with histone deacetylase. (A) In vivo interaction between Aiolos isoforms and components of the Mi-2/
NurD and SIN3 histone deacetylase complexes. Immunoprecipitation of Aiolos was accomplished using an anti-FLAG antibody and eluates
were tested by immunoblot analysis with anti-FLAG, anti-HDAC1, anti-SIN3A and three antibodies that each distinguish a subfraction of the
Mi-2/NuRD complex, namely anti-MTA1, anti-MTA2 and anti-MTA3. Input COS-7 cell extracts were tested for all antibodies (not shown).
(B) Confocal images of untransfected COS-7 cells showing distribution of HDAC1, SIN3A and MTA2. (C) Confocal images of COS-7 cells
transfected with different Aiolos isoforms. Aiolos isoforms were stained with an anti-FLAG and a secondary anti-mouse labeled with Cy2
(green). HDAC1, MTA2 and SIN3A were labeled with Cy3 (red). Nuclei were counterstained with DAPI (blue).
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performing a chromatin immunoprecipitation (ChIP) analysis
(Orlando, 2000). This assay can determine whether a particular
transcriptional factor (Aiolos, in this case) is bound to a
specific promoter in its natural chromatin state (in this case,
the promoter of downregulated genes obtained from the
microarray analysis). Immunoprecipitated DNA with anti-
FLAG antibodies and Anti-Aiolos antiserum was then
analyzed by PCR with specific primers for the promoters.
Before the primers were designed we studied a fragment
containing the DNA binding site for Aiolos (TGGGAA). We
found Aio-1 to be specifically associated with the promoter of
SIRT1 (Fig. 6A), which implies a potential role for Aiolos in
the regulation of SIRT1 expression. ChIP analysis with the
remaining isoforms showed that Aio-5 and Aio-1-5a were
both also associated with the SIRT-1 promoter (Fig. 6A). As
expected, Aio-3,4,5 and Aio-3,4,5,6, which lack the DNA-
binding motifs, do not associate with the SIRT1 promoter.
Aiolos isoforms in B cells
As introduced above, Aiolos has a key role in hematopoietic
differentiation, in particular in B cells. Although the Aiolos
isoforms analyzed in the present study were identified and
isolated in B cells, all the above experiments were performed
in COS-7, a fibroblast cell line. As described, this system is
ideal for several reasons. However, the results obtained might
depend on that particular cell context and it is important to
assess whether these results are relevant to the B-cell system.
In order to investigate some of the properties described above
in a cell type more relevant to the hematopoietic system we
decided to use two cell types: RAJI cells, a Burkitt’s lymphoma
cell line derived from B lymphocytes, and B-cell-derived
lymphoblastoid cells, an Epstein-Barr virus (EBV)-
transformed lymphoblastoid cell line. These two cell types
express Aiolos (data not shown) and can be transfected with
FLAG-tagged Aiolos expression vectors to investigate the
properties of Aiolos isoforms.
Interestingly, immunocytochemistry experiments in
transiently transfected RAJI and B-PBL cells revealed an
isoform-specific distribution very similar to that obtained in
COS-7 cells (Fig. 7A). Similar to experiments with COS-7
cells, in RAJI and B-PBL cells the Aio-1 and Aio-5 isoforms
are found in the nucleus, with a diffuse distribution in the
majority of cells and a more restricted speckled distribution in
a smaller fraction of cells. Interestingly, the Aio-3,4,5,6
isoform, which lacks the DNA-binding domain and is
predominantly localized in the cytoplasm and membrane in
COS-7 cells (Fig. 2C), is present as two populations in RAJI
and B-PBL cells, the predominant one in nuclei, cytosol and
membranes, and a second one where it is excluded from the
nuclei (Fig. 7A,B). This can easily be explained if we take into
account that endogenous Aiolos (or Ikaros), expressed in RAJI
and B-PBL cells, can dimerize with isoform Aio-3,4,5,6.
These results would be in agreement with the data shown in
Fig. 3, where co-transfection with Ik-1 modulates isoform Aio-
3,4,5,6 localization.
When studying colocalization of Aiolos isoforms with
HDAC1 in RAJI and B-PBL cells, we observed a high degree
of colocalization between the Aiolos fraction in the nucleus
and HDAC1 (Fig. 7B). We found that the cytosolic fraction of
Aio-3,4,5,6 and Aio-1-5a do not colocalize with HDAC1, in
agreement with data obtained in COS-7 cells.
Discussion
It is well established that many human genes are alternatively
Fig. 5. Effects on global histone acetylation
patterns of COS-7 cells transfected with Aiolos
isoforms. (A) Western blot analysis of histone
modifications of cell extracts. Analysis with
antibodies against acetyl-H4, acetyl K16 and
K8 of H4, acetyl-H3 and acetyl K9 of histone
H3. A Coomassie Blue staining is also shown
as a loading control. (B) Analysis of histone H4
acetylation by high performance capillary
electrophoresis (HPCE). An example of HPCE
separation of acetylated species of histone H4
from pcDNA3 and Aiolos-transfected COS-7
cells. The non-acetylated (Ac0),
monoacetylated (Ac1) and diacetylated (Ac2)
forms of histone H4 are indicated. (C) A
quantification of the HPCE analysis showing
the acetylation of histone H4 corresponding to
COS-7 cells transfected with all Aiolos
isoforms.
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spliced and that this multiplicity is an effective way to increase
the diversity of proteins derived from a single gene. These
proteins generated by alternative splicing can differ in subtle
or dramatic ways by deleting regions involved in interactions
with partners or localization (Lareau et al., 2004). All the
Ikaros family members, master regulators of hematopoietic
differentiation, exhibit multiple isoforms, including Aiolos, the
object of our study. The prevalence of alternatively spliced
Ikaros family proteins raises intriguing questions regarding
their function and the selective advantage that they may confer.
At any rate, the alternative splicing affecting defined functional
domains appears to be an effective way of regulating their
biological behavior. Furthermore, the ability of Ikaros family
members to homo- and heterodimerize adds an extra layer of
complexity, since modulation involves the dimers and
multimers of multiple isoforms of different Ikaros family
members.
We have examined the features that make different isoforms
unique: how the presence of different combinations of
functional domains is reflected in a range of biological
properties including cell localization, association with Ikaros
and various components of histone deacetylase complexes;
effects on histone acetylation; and association with putative
target genes. These results are summarized in Table 1. They
indicate that the full-length isoform of Aiolos, Aio-1, possesses
all the major functions, as would be anticipated from an
appreciation of its well-defined functional domains, consistent
with previous findings (Koipally et al., 1999). Moreover, we
have confirmed that the remaining isoforms have lost function
associated with the missing functional domain. We propose
that the isoforms that lack certain domains and show a partial
loss of function could probably have an important role in
modulating the activity of full-length isoforms by interacting
with them. This is observed in experiments in which Aiolos
isoforms have been co-transfected with Ikaros. For example,
the co-transfection of Aio-3,4,5,6 and full-length Ikaros
isoform (Ik-1) results in a change of cellular distribution of
both proteins, probably as a result of heterodimerization.
Regarding the cellular distribution of the Aio-3,4,5,6
isoform, we have observed an interesting difference with
respect to that of Aio-3,4,5, which only differs in exon 6. This
finding has prompted us to propose the existence of a nuclear
localization signal in exon 6. Although no consensus NLS has
been described, most of the experimentally characterized NLSs
are monopartite and bipartite motifs, both of which are
characterized by clusters rich in basic amino acid residues
(Cokol et al., 2000). Exon 6 is particularly rich in basic amino
acid residues and has indeed a much more basic pKa than that
of the full-length protein (11.18 versus 6.15). Therefore, we
suggest that this high concentration of basic residues in exon
6 may indicate an NLS. This is supported by the findings of
studies of isoform Aio-1-5a (see Fig. 2C), which possesses an
intact DNA binding domain but a distinct C-terminal region
that contains exon 5a, but not exons 6 and 7, and shows both
a nuclear and cytoplasmic punctuate distribution. Schmitt et al.
(Schmitt et al., 2002) have suggested that Tyr 286,
corresponding to exon 7 from the genomic sequence, is
involved in nuclear localization, as Tyr to Thr abrogates
translocation to the nucleus, whereas other mutants do not
exhibit such an effect. Our results indicate that nuclear
localization depends not only on Tyr 286 in exon 6 but also on
the presence of exon 6.
It has been suggested that alternative splicing often creates
novel isoforms by the insertion of new, functional protein
sequences that probably originate from non-coding sequences
of introns. This appears to be the case with Aio-1-5a and Aio-
4-5a, two novel isoforms described in this report that lack the
dimerization domain at the C-terminus. We have analyzed and
compared the functionality of Aio-1-5a in our study. This
isoform exhibits nuclear and cytoplasmic localization and
interacts weakly with Mi-2/NuRD and SIN3 histone
deacetylase complexes. Immunofluorescence analyses have
shown a small overlap with Ikaros, reinforcing the notion that
absence of the C-terminal dimerization motif prevents
interaction with other Ikaros family members. However, we
have observed that transfection with Aio-1-5a affects global
acetylation status, and binding to SIRT1 has been
demonstrated. These findings suggest that the activity of these
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Fig. 6. Analysis of the interaction of Aiolos isoforms with the promoter of SIRT1. (A) ChIP assays were performed with anti-FLAG, anti-
Aiolos and anti-RNA pol II antibodies in COS-7 cells transfected with all the Aiolos isoforms studied in this work. Negative controls (No
antibody, NAB) are also shown. Input and bound fractions are shown. In addition to the SIRT1 promoter, actin B gene promoter was used as a
negative control. (B) Association of Aiolos to the SIRT1 promoter in B cells. ChIP assays in untransfected RAJI and B-PBL cells. Anti-Aiolos
and anti-RNA pol II antibodies were used. Actin B was used as a negative control.
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isoforms is independent of the interaction with other Ikaros
family members.
An expression microarray study performed with Aio-1
revealed that SIRT1, a NAD+-dependent histone deacetylase is
downregulated in cells transfected with Aio-1. This finding is
particularly interesting considering that SIRT1 has been
associated with the formation of facultative heterochromatin
(Vaquero et al., 2004) and Aiolos is localized in
pericentromeric heterochromatin during some phases of the
cell cycle. But we have observed that not only Aio-1 but also
Aio-5 and Aio-1-5a (which have different properties from the
full-length isoform, as described in this work; see Fig. 6)
associate with the SIRT1 promoter. Remarkably, the generality
of our conclusions with COS-7 cells is highlighted by the fact
that Aiolos also binds the promoter of SIRT1 in both RAJI and
B-PBL cells (Fig. 6B). We may speculate that the expression
of different combinations of Aiolos isoforms would modulate
the effects on the expression levels of SIRT1. In addition,
isoforms lacking more than three zinc
fingers of the DNA-binding domain, such
as Aio-3,4,5,6, might quench a fraction
of Aio-1 and therefore reduce the fraction
of Aio-1 interacting with the SIRT1
promoter.
In this study we have analyzed the
expression patterns of Aiolos isoforms in
cells derived from different lymphoid
malignancies and samples from
individuals diagnosed with rheumatoid
arthritis and systemic lupus
erythematosus, in which lymphocyte
function is misregulated. These analyses
have led us to identify a number of novel
isoforms, although we found no specific
patterns of isoform expression. The
absence of such patterns does not rule out
the possible involvement or contribution
of these isoforms to the disease. In fact,
Aiolos-deficient mice (Wang et al., 1998;
Sun et al., 2003) develop the symptoms of
human systemic lupus erythematosus.
The analysis of Aiolos isoforms in
different cell types, by transfection
experiments, has allowed their potential
individual contribution to Aiolos function
to be predicted. Our findings attest to the
complexity of regulation by the
combinations of splice variants. It is
likely that subtle differences in the levels
of expression account for significant
alterations in Aiolos function and thereby
the misregulation of key genes in
lymphocyte behavior.
Fig. 7. Transfection of Aiolos isoforms in B
cells. (A) Subcellular localization of Aiolos
isoforms. Confocal images of RAJI and B-
PBL cells transfected with different Aiolos
isoforms and labeled with Aiolos antibody
(green). Nuclear DNA was counterstained
with DAPI (blue). Images of different
subpopulations are included (indicated in
Results). (B) Association of Aiolos isoforms
with histone deacetylase. Confocal images of
RAJI and B-PBL cells transfected with
different Aiolos isoforms. Aiolos isoforms
were stained with anti-FLAG and a secondary
anti-mouse antibody, labeled with Cy2
(green). HDAC1 was labeled with Cy3 (red).
Nuclei were counterstained with DAPI (blue).
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Materials and Methods
Materials
The following cell lines were used: hematopoietic cell lines derived from human
B leukemic (697, RAMOS, RS11;846, REH) and T leukemic (JURKAT, SUPT11,
MOLT4, MOLT16) cells, myeloid cell lines (HL-60, MV4;11), lymphoma cell
lines (NAMALWA, RAJI), the NKL cell line, derived from natural killer (NK) cells
and a B-cell-derived EBV-transformed lymphoblastoid cell line (B-PBL). Also,
non-hematopoietic cell lines (monkey SV40 transformed fibroblast cell line COS-
7, the breast cell line MCF 7, liver cell line HEPG2, a neuroblastoma-derived cell
line SHSY-5Y and kidney cell line HEK) were analyzed. Cell lines were
maintained in RPMI1640 (Bio-Whittaker) or DMEM (Gibco, Invitrogen)
supplemented with 10% fetal calf serum (FCS; HyClone) and 1% penicillin-
streptomycin (Bio-Whittaker). In addition, mononuclear cells were obtained from
peripheral blood of rheumatoid arthritis patients, systemic lupus erythematosus
patients and healthy donors who gave informed consent to the study. Peripheral
lymphocytes were purified by gradient centrifugation using Ficoll (Histopaque®-
1077, Sigma).
Cell transfections
Transient transfection of COS-7 cells was performed with Lipofectamine 2000
reagent (Invitrogen) following the instructions of the manufacturer. In the case of
RAJI and B-PBL cells, transient transfection was performed by electroporating 107
cells in 0.8 ml PBS with 40 g of the vector at 250 V and 975 F. After
electroporation, cells were washed with PBS and seeded at 106 cells/ml in fresh
medium containing 20% FBS.
RNA extraction and reverse transcription-polymerase chain
reaction (RT-PCR) analysis
Total RNA was isolated from human B- and T-leukemic cell lines and non-
haematopoietic cell lines as well as from mononuclear cells obtained from
peripheral blood of both patients and healthy volunteers, using Trizol (Invitrogen).
cDNA synthesis was performed with the IMPROM-II kit (Promega) from total RNA
(2 g). RT-PCR was performed with primers designed in exon 1 (Aiol-ex1F, 5-
ATGGAAGATATACAAACAAATGCGGA-3) and exon 7 (Aiol-ex7R, 5-AGA -
GAGGCCTGTGTGAGAAGGCAC-3) for 35 cycles (94°C for 30 seconds, 55°C
for 30 seconds, and 72°C for 1 minute) in a final volume of 25 l containing 1
PCR buffer (Gibco-BRL), 1.5 mM MgCl2, 0.3 mM dNTP, 0.25 mM of each primer
and 2 IU Taq polymerase (Gibco-BRL). GAPDH was used as an internal control to
ensure cDNA quality and loading accuracy. Amplification products were resolved
by agarose gel electrophoresis and visualized by ethidium bromide staining.
DNA hybridization
PCR products were blotted onto nylon membranes (Hybond-N+, Amersham
Biosciences) and hybridized with a specific probe to confirm the specificity of
amplification. DNA was cross-linked to the membrane by exposure to UV light.
Membranes were prehybridized for 30 minutes and hybridized with an Aiolos probe,
corresponding to a common region of all Aiolos isoforms and labeled with [-
32P]dATP, for 5-6 hours. Membranes were then washed and exposed using high-
sensitivity autoradiographic films with an intensifying screen (Agfa).
Isolation, cloning and sequencing of Aiolos isoforms
PCR products were separated by electrophoresis in TBE agarose gels and isolated
from them using a SephaGlass BandPrep kit (Amersham Biosciences). The purified
products were TA-cloned into the pGEM-T Easy Vector System (Promega) and
sequenced in an ABI373 DNA sequencer (Applied Biosystems). The new isoforms
were submitted to the GeneBank database, where they are listed under the following
accession numbers: AY377973, AY377975, AY377976, AY377977, AY377978,
AY377979, AY377980, AY377981 and AY377982.
The start codon of Aio-1, Aio-5a, Aio-5, Aio-3,4,5 and Aio-3,4,5,6 cDNAs
was replaced with a NotI restriction site by PCR mutagenesis using a specific
primer (5-GCGGCCGCGGAAGATATACAAACAAA-3). This restriction site
was used to tag a FLAG epitope at the 5 end of the sequences maintaining the
open reading frame of the transcripts. Constructions were subcloned into pCDNA3
vector at the NotI site for expression studies. All constructs were verified by DNA
sequencing.
Immunoprecipitation and western blot analysis
FLAG-tagged Aio-1, Aio-5a, Aio-5, Aio-3,4,5 and Aio-3,4,5,6 subcloned in
pCDNA3-FLAG vector were transiently transfected with Lipofectamine-2000
(Invitrogen) into COS-7, which do not express Aiolos, following standard
procedures. Cells were lysed with 1 ml of lysis buffer (50 mM Tris HCl, pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Triton X-100) and Complete EDTA-free (Roche)
and FLAG-tagged proteins were immunoprecipitated with a mouse monoclonal
anti-FLAG antibody (Sigma). Samples were loaded onto 10-12% SDS-
polyacrylamide gels and electroblotted onto polyvinylidene difluoride (PVDF)
membranes (Hybond-P, Amersham Biosciences). Immunodetection was
performed with the following primary antibodies diluted in blocking solution
(TBS-T-1% BSA): Anti-HDAC1 (ABR), anti-MTA1 (Abcam), Anti-MTA2
antibody (Abcam), Anti-MTA3 antibody (Abcam), Anti-SIN3A (Upstate),
anti-Ikaros (M-20) (Santa Cruz Biotechnology), anti-FLAG antibody (Sigma). A
rabbit polyclonal anti-Aiolos antiserum was made against a linear peptide
corresponding to amino acids 5-18 of human Aiolos (QTNAELKSTQEQSVP).
This antiserum recognizes all Aiolos isoforms. The secondary antibodies used
were goat anti-rabbit conjugated to horseradish peroxidase (Amersham
Biosciences) and sheep anti-mouse horseradish peroxidase (Amersham
Biosciences). Blots were developed with the ECL Blotting Detection System
(Amersham Biosciences).
Staining with fluorescent DNA probes and fluorescence
microscopy
pCDNA3-FLAG-tagged Aiolos proteins were transiently transfected into cells
previously plated overnight under poly-L-lysine-coated glass coverslips (106
cells/well for a six-well plate). Cells were fixed in 4% formaldehyde for 30 minutes
at room temperature and permeabilized with phosphate-buffered saline-0.5% Triton
X-100 for 10 minutes at room temperature. Staining with different antibodies,
diluted in PBS buffer with 1% fetal bovine serum to block the non-specific antibody
binding sites, was performed: Anti-HDAC1 (ABR), Anti-MTA2 antibody (Abcam),
anti-SIN3A (Upstate), anti-Ikaros (M-20) (Santa Cruz Biotechnology), and anti-
FLAG antibody (Sigma). Secondary antibodies used included anti-mouse IgG Cy3
conjugate and anti-rabbit IgG Cy2 conjugate (Jackson ImmunoResearch). DAPI
(Dako) was used to stain the nucleus. Confocal optical sections were obtained using
a Leica TCS SP confocal microscope (Leica Microsystems, Heidelberg GMbH)
equipped with krypton and argon lasers, and images were processed using Adobe
Photoshop 6.0 (Adobe Systems Inc.).
Isolation and western blotting of histones
Histones were acid-extracted from cell pellets in 0.25 M HCl and then acetone-
precipitated (Fraga et al., 2005). Samples were separated on a 15% SDS-PAGE gel
and blotted onto a 22-m pore PVDF membrane (Immobilon PSQ; Millipore). The
following rabbit polyclonal antibodies were used: anti-histone H3 (Abcam) directed
against a C-terminal peptide of H3, anti-acetyl histone H3 (Upstate Biotechnologies,
Inc.), anti-acetyl K9 histone H3 (Abcam), anti-histone H4 (Upstate Biotechnologies,
Inc.), anti-acetyl histone H4 (Upstate Biotechnologies, Inc.), anti-acetyl K8 histone
H4 (Abcam), and anti-acetyl K16 histone H4 (Upstate Biotechnologies, Inc.).
Secondary antibodies used include anti-mouse and anti-rabbit IgG horseradish
peroxidase conjugates (Amersham Biosciences) developed using ECL
immunodetection reagents (Amersham Biosciences).
Quantification of global histone acetylation by high-
performance capillary electrophoresis
The degree of histone acetylation was quantified by a modification of a previously
described method (Fraga et al., 2005). Individual histones were fractionated by
reversed-phase high-performance liquid chromatography (HPLC) on a Delta-Pak
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Table 1. Summary of the properties of the five Aiolos isoforms studied
Aio-1 Aio-5 Aio-3,4,5 Aio-3,4,5,6 Aio-1.5a
Nuclear localization * * * *
Cytosolic localization * *
Heterodimerization with Ikaros * * * *
HDAC1 interaction ++++ + ++ + +
Sin3 interaction +
MTA2 interaction ++++ + ++ + +
Effects of histone acetylation * * *
Interaction with SIRT1 promoter * * *
*, property is present/exhibited by the corresponding isoform; +, property is present at the level indicated (+, ++, +++).
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C18 column (Waters) eluted with an acetonitrile gradient (20–60%) in 0.3%
trifluoroacetic acid using a Beckman HPLC gradient system. Purity of histones
was measured by PAGE. The non-, mono-, di-, tri- and tetraacetylated histone
derivatives of H3 fraction were resolved by high-performance capillary
electrophoresis (HPCE). An uncoated fused silica capillary (Beckman-Coulter;
60.2 cm  75.0 mm, effective length 50.0 cm) was used in a CE system (P/ACETM
MDQ; Beckman-Coulter) connected to a data-processing station (32 KaratTM
Software). The running buffer was 110 mM phosphate buffer, pH 2.0, containing
0.03% (w/v) hydroxylpropylmethyl-cellulose. Running conditions were 25°C and
an operating voltage of 12 kV. On-column absorbance was monitored at 214 nm.
Before each run, the capillary system was conditioned by washing with 0.1 M
NaOH for 3 minutes and 0.5 M H2SO4 for 2 minutes and equilibrated with the
running buffer for 3 minutes. Samples were injected under pressure (0.3 psi) for 3
seconds. Triplicate samples were obtained and all samples were analyzed twice.
Error bars in graphs represent standard deviations. Student’s t-test was used to
compare acetylation values (a P value <0.05 was considered to be statistically
significant).
Chromatin immunoprecipitation (ChIP) assays
Standard ChIP assays were performed as previously described (Ballestar et al.,
2003) using the anti-FLAG antibody and anti-Aiolos antiserum described above.
In addition, a polyclonal antibody against RNA polymerase II (Abcam) was used
as a positive control. Cell lysates were sonicated for 20 minutes with 30-second
on-and-off cycles at the high setting of a Bioruptor (Diagenode) to produce
chromatin fragments of 0.5 kb on average. At least three independent ChIP
experiments were performed. PCR amplification was performed with specific
primers for each of the analyzed promoters. For each promoter, the sensitivity of
PCR amplification was evaluated in serial dilutions of total DNA collected after
sonication (input fraction). Primer sequences to amplify the SIRT1 promoter are
located around 300 bp upstream of the transcription start site and contain a
consensus DNA binding site for Aiolos (TGGGAAA). The primers sequences
are: forward SIRT1, TGCA CGTGAGAAAACTGAGG and reverse SIRT1,
GCTCCCTGAAATACGTTGGA. The promoter of the actin B gene was used as a
control. Primer sequences, located at both sides of the transcription start site were:
forward ACTB, CTCAATC TCGCTCTCGCTCT and reverse ACTB, CAAA -
GGCGAGGCTCTGTG. The criteria used to establish a positive result of Aiolos
association were based on: (1) conditions of amplification in the linear range were
optimized by PCR amplification of serial dilutions of total DNA collected after
sonication (input fraction); (2) negative controls (no antibody) and input were
included for each PCR experiment; (3) a minimum of three independent ChIP
experiments were performed.
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